• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary
    Books
    Consumer Discretionary
    Get the next $WLY alert in real time by email

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025.

    SECOND QUARTER SUMMARY

    • GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14%
    • Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14% and margin of 18.8% up 250 basis points; Adjusted EBITDA of $115 million up 8% and margin of 27.3% up 240 basis points; and Adjusted EPS of $1.10 up 12%
    • Delivered strong growth and margin expansion in Research driven by global demand to publish, read, and license
    • Executed $6 million content licensing project for AI model training; $35 million realized year-to-date
    • Reduced Corporate Expenses (Adjusted EBITDA) by 18% at constant currency as part of multi-year margin expansion initiatives
    • Delivered YTD Operating Cash Flow and Free Cash Flow improvement of 19% and 17%, respectively
    • Increased share repurchases by 69% over prior year period to $21 million with Wiley's dividend yield around 3.9%

    MANAGEMENT COMMENTARY

    "We continue to deliver strong performance in Research and accelerating momentum in AI as we capitalize on record research volume and expanding corporate R&D opportunities," said Matthew Kissner, President and CEO. "In Research, strong global demand is driving defensible growth in our recurring revenue and open access models. In AI, we are turning high-value knowledge into impact through the execution of content licensing projects for large language models and corporate AI applications. Finally, operational excellence and margin expansion are a way of life for us as we continuously optimize our cost structure, drive investment and expense discipline, and advance our transformative publishing platform."

    FINANCIAL SUMMARY

    Please see the accompanying financial tables for more detail.

    Research

    • Q2 Research revenue of $279 million was up 6% as reported and 5% at constant currency driven by 7% growth in Research Publishing including AI revenue of $5 million. Article submissions and output rose by 28% and 12%, respectively, with robust growth across all key geographies. Strong volume drove double-digit growth in author-funded open access and solid growth in Wiley's recurring revenue models, combining subscriptions and transformational agreements. Year-to-date, Research revenue was up 6% as reported and 5% at constant currency.
    • Q2 Adjusted EBITDA of $93 million was up 14% as reported and 13% at constant currency driven by revenue growth and cost savings initiatives. Adjusted EBITDA margin for the quarter was 33.5% vs. 31.3% in the prior year period. Year-to-date, Research Adjusted EBITDA was up 8% as reported and at constant currency.

    Learning

    • Q2 Learning revenue of $143 million was down 11% as reported and at constant currency due to market-related softness, including a sharp inventory drop off at an online retailer and a slowdown in consumer and corporate spending. Professional was down 16%. Academic was down 8%. Learning was also impacted by $4 million of AI revenue in the prior year. Across the segment, print declines more than offset digital growth. Year-to-date, Learning revenue was down 10% as reported and at constant currency. Declines are expected to moderate in the second half of the year as retail inventory levels stabilize.
    • Q2 Adjusted EBITDA of $57 million for the quarter was down 14% as reported and at constant currency due to lower revenue. Adjusted EBITDA margin was 40.1% down from 41.3%. Year-to-date, Learning Adjusted EBITDA was down 12% as reported and at constant currency.

    Corporate Expenses

    "Corporate Expenses" are the portion of shared services costs not allocated to segments.

    • Q2 Corporate Expenses on an Adjusted EBITDA basis were lower by 18% as reported and at constant currency due to restructuring efforts and expense management across functional areas, notably Technology. Year-to-date, Corporate Expenses on an Adjusted EBITDA basis were lower by 7% as reported and 8% at constant currency.

    EPS

    • Q2 GAAP EPS of $0.84 compared to $0.74 in prior year period. Q2 Adjusted EPS of $1.10 was up 12% at constant currency with operating performance offsetting a higher adjusted effective tax rate. Diluted shares outstanding were down by 1.3 million to 53.5 million. Year-to-date, GAAP EPS rose 48% on a reported basis and Adjusted EPS was up 9% at constant currency.

    BALANCE SHEET, CASH FLOW, AND CAPITAL ALLOCATION

    • Net Debt-to-EBITDA Ratio (Trailing Twelve Months) at quarter end was 2.0 compared to 2.2 in the year-ago period. Wiley recently utilized approximately $120 million of divestiture proceeds to reduce debt and expects leverage to come down materially in Fiscal 2026.
    • Net Cash Used in Operating Activities was $77 million compared to $94 million in the prior year period. Note, Wiley's regular use of cash in the first half of the fiscal year is driven by the timing of cash collections for annual journal renewals, which are concentrated in Q3 and Q4.
    • Free Cash Flow improved to a use of $108 million from a use of $130 million in the prior year largely due to higher cash earnings and lower capex and interest payments. Capex was $31 million compared to $36 million.
    • Returns to Shareholders: Wiley allocated $40 million in the quarter toward both repurchases ($21 million) and dividends ($19 million), up 26% over prior year. The Company acquired approximately 553,000 shares at an average cost of $38.11/share. Year-to-date, Wiley allocated $73 million to repurchases and dividends. During the first half, the Board approved a $250 million share repurchase authorization, deployed a 10b5-1 plan for repurchases outside open windows, and raised its dividend for the 32nd consecutive year.

    FISCAL 2026 OUTLOOK

    Wiley is reaffirming its full year outlook for Adjusted EBITDA margin, Adjusted EPS, and Free Cash Flow and narrowing its Revenue guidance to the low end of the range due to market challenges in Learning. Research and AI momentum are expected to remain strong. The revenue range is narrowed to low-single digit growth from low-to-mid single digit growth.

    Metric

    Fiscal 2024 Results

    Fiscal 2025 Results

    Fiscal 2026 Outlook

    Adj. Revenue

    $1,617M

    $1,660M

    Low-single digit growth*

    Adj. EBITDA Margin

    22.8%

    24%

    25.5% to 26.5%

    Adj. EPS

    $2.78

    $3.64

    $3.90 to $4.35

    Free Cash Flow

    $114M

    $126M

    Approximately $200M

    *Narrowed from low-to-mid single digit growth

    Adjusted metrics exclude impact of divestitures, which were primarily completed in Fiscal 2024 with remainder completed in first half of Fiscal 2025. Approximately $17 million of divestiture-related revenue was recorded in Fiscal 2025.

    EARNINGS CONFERENCE CALL

    Scheduled for today, December 4 at 10:00 am (ET). Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606. U.S. callers, please dial (888) 210-3346 and enter the participant code 2521217#. International callers, please dial (646) 960-0253 and enter the participant code 2521217#.

    ABOUT WILEY

    Wiley (NYSE:WLY) is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.

    NON-GAAP FINANCIAL MEASURES

    Wiley provides non-GAAP financial measures and performance results such as "Adjusted EPS," "Adjusted Operating Income and Margin," "EBITDA, Adjusted EBITDA and Margin," "Adjusted Income before Taxes," "Adjusted Income Tax Provision," "Adjusted Effective Tax Rate," "Free Cash Flow less Product Development Spending," "Adjusted Revenue," and results on a Constant Currency basis to assess underlying business performance and trends. Management believes non-GAAP financial measures, which exclude the impact of restructuring charges and credits and certain other items, and the impact of divestitures and acquisitions provide a useful comparable basis to analyze operating results and earnings. See the reconciliations of non-GAAP financial measures and explanations of the uses of non-GAAP measures in the supplementary information. We have not provided our 2026 outlook for the most directly comparable U.S. GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, gains and losses on foreign currency, and other gains and losses. These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with U.S. GAAP.

    FORWARD-LOOKING STATEMENTS

    This release contains certain forward-looking statements concerning the Company's operations, performance, and financial condition. Reliance should not be placed on forward-looking statements, as actual results may differ materially from those in any forward-looking statements. Any such forward-looking statements are based upon a number of assumptions and estimates that are inherently subject to uncertainties and contingencies, many of which are beyond the control of the Company and are subject to change based on many important factors. Such factors include, but are not limited to: (i) the level of investment in new technologies and products; (ii) subscriber renewal rates for the Company's journals; (iii) the financial stability and liquidity of journal subscription agents; (iv) the consolidation of book wholesalers and retail accounts; (v) the market position and financial stability of key online retailers; (vi) the seasonal nature of the Company's educational business and the impact of the used book market; (vii) worldwide economic and political conditions; (viii) the Company's ability to protect its copyrights and other intellectual property worldwide (ix) the ability of the Company to successfully integrate acquired operations and realize expected opportunities; (x) the ability to realize operating savings over time and in fiscal year 2026 in connection with our multiyear Global Restructuring Program and completed dispositions; (xi) cyber risk and the failure to maintain the integrity of our operational or security systems or infrastructure, or those of third parties with which we do business; (xii) as a result of acquisitions, we have and may record a significant amount of goodwill and other identifiable intangible assets and we may never realize the full carrying value of these assets; (xiii) our ability to leverage artificial intelligence technologies in our products and services, including generative artificial intelligence, large language models, machine learning, and other artificial intelligence tools; and (xiv) other factors detailed from time to time in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise forward-looking statements to reflect subsequent events.

    CATEGORY: EARNINGS RELEASES

     
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1) (2)
    CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME
    (in USD thousands, except per share information)
    (unaudited)
     
    Three Months Ended Six Months Ended
    October 31, October 31,

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenue, net

    $

    421,751

     

    $

    426,595

     

    $

    818,551

     

    $

    830,404

     

    Costs and expenses:
    Cost of sales

     

    104,388

     

     

    107,000

     

     

    213,647

     

     

    216,220

     

    Operating and administrative expenses

     

    225,087

     

     

    238,891

     

     

    465,417

     

     

    487,710

     

    Restructuring and related charges

     

    6,032

     

     

    3,627

     

     

    9,070

     

     

    7,497

     

    Amortization of intangible assets

     

    13,248

     

     

    12,944

     

     

    26,458

     

     

    25,871

     

    Total costs and expenses

     

    348,755

     

     

    362,462

     

     

    714,592

     

     

    737,298

     

     
    Operating income

     

    72,996

     

     

    64,133

     

     

    103,959

     

     

    93,106

     

    As a % of revenue

     

    17.3

    %

     

    15.0

    %

     

    12.7

    %

     

    11.2

    %

     
    Interest expense

     

    (11,670

    )

     

    (14,463

    )

     

    (22,712

    )

     

    (27,250

    )

    Net foreign exchange transaction gains (losses)

     

    956

     

     

    (3,328

    )

     

    (15

    )

     

    (3,094

    )

    Net (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale

     

    (2,309

    )

     

    369

     

     

    (3,425

    )

     

    6,170

     

    Other (expense) income, net

     

    (1,963

    )

     

    2,226

     

     

    (2,090

    )

     

    3,008

     

     
    Income before taxes

     

    58,010

     

     

    48,937

     

     

    75,717

     

     

    71,940

     

     
    Provision for income taxes

     

    13,119

     

     

    8,479

     

     

    19,126

     

     

    32,918

     

    Effective tax rate

     

    22.6

    %

     

    17.3

    %

     

    25.3

    %

     

    45.8

    %

    Net income

    $

    44,891

     

    $

    40,458

     

    $

    56,591

     

    $

    39,022

     

    As a % of revenue

     

    10.6

    %

     

    9.5

    %

     

    6.9

    %

     

    4.7

    %

     
    Earnings per share
    Basic

    $

    0.85

     

    $

    0.75

     

    $

    1.06

     

    $

    0.72

     

    Diluted

    $

    0.84

     

    $

    0.74

     

    $

    1.05

     

    $

    0.71

     

     
    Weighted average number of common shares outstanding
    Basic

     

    53,089

     

     

    54,191

     

     

    53,233

     

     

    54,284

     

    Diluted

     

    53,515

     

     

    54,850

     

     

    53,735

     

     

    54,928

     

     
     
    Notes:
    (1) The supplementary information included in this press release for the three and six months ended October 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
    (2) All amounts are approximate due to rounding.
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1) (2)
    RECONCILIATION OF US GAAP MEASURES to NON-GAAP MEASURES
    (in USD thousands, except per share information)
    (unaudited)
     
    Reconciliation of US GAAP Earnings per Share to Non-GAAP Adjusted EPS
    Three Months Ended Six Months Ended
    October 31, October 31,

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    US GAAP Earnings Per Share - Diluted

    $

    0.84

     

    $

    0.74

     

    $

    1.05

     

    $

    0.71

     

    Adjustments:
    Restructuring and related charges

     

    0.09

     

     

    0.06

     

     

    0.14

     

     

    0.12

     

    Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments

     

    (0.02

    )

     

    0.04

     

     

    (0.01

    )

     

    -

     

    Amortization of acquired intangible assets

     

    0.22

     

     

    0.21

     

     

    0.42

     

     

    0.40

     

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

     

    0.04

     

     

    -

     

     

    0.06

     

     

    (0.08

    )

    Held for Sale or Sold segment Adjusted Net Loss

     

    -

     

     

    0.01

     

     

    -

     

     

    0.05

     

    Legal settlement

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    Income tax adjustments

     

    (0.07

    )

     

    (0.09

    )

     

    (0.07

    )

     

    0.24

     

    Non-GAAP Adjusted Earnings Per Share - Diluted

    $

    1.10

     

    $

    0.97

     

    $

    1.59

     

    $

    1.44

     

     
    Reconciliation of US GAAP Income Before Taxes to Non-GAAP Adjusted Income Before Taxes
    Three Months Ended Six Months Ended
    October 31, October 31,

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    US GAAP Income Before Taxes

    $

    58,010

     

    $

    48,937

     

    $

    75,717

     

    $

    71,940

     

    Pretax Impact of Adjustments:
    Restructuring and related charges

     

    6,032

     

     

    3,627

     

     

    9,070

     

     

    7,497

     

    Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments

     

    (1,111

    )

     

    2,943

     

     

    (1,550

    )

     

    351

     

    Amortization of acquired intangible assets

     

    13,248

     

     

    12,944

     

     

    26,458

     

     

    25,913

     

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

     

    2,309

     

     

    (369

    )

     

    3,425

     

     

    (6,170

    )

    Held for Sale or Sold segment Adjusted Loss Before Taxes

     

    -

     

     

    1,059

     

     

    -

     

     

    3,578

     

    Legal settlement

     

    108

     

     

    -

     

     

    108

     

     

    -

     

    Non-GAAP Adjusted Income Before Taxes

    $

    78,596

     

    $

    69,141

     

    $

    113,228

     

    $

    103,109

     

     
    Reconciliation of US GAAP Income Tax Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate
     
    US GAAP Income Tax Provision

    $

    13,119

     

    $

    8,479

     

    $

    19,126

     

    $

    32,918

     

    Income Tax Impact of Adjustments (3)
    Restructuring and related charges

     

    1,271

     

     

    161

     

     

    1,790

     

     

    911

     

    Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments

     

    (217

    )

     

    729

     

     

    (967

    )

     

    338

     

    Amortization of acquired intangible assets

     

    2,133

     

     

    1,792

     

     

    4,126

     

     

    3,601

     

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

     

    -

     

     

    (588

    )

     

    54

     

     

    (1,513

    )

    Held for Sale or Sold segment Adjusted Tax Benefit

     

    -

     

     

    515

     

     

    -

     

     

    887

     

    Legal settlement

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    Income Tax Adjustments
    Impact of valuation allowance on the US GAAP effective tax rate

     

    (212

    )

     

    4,911

     

     

    29

     

     

    (13,119

    )

    Impact of change in Germany statutory tax rate on deferred tax balances

     

    3,869

     

     

    -

     

     

    3,869

     

     

    -

     

    Non-GAAP Adjusted Income Tax Provision

    $

    19,963

     

    $

    15,999

     

    $

    28,027

     

    $

    24,023

     

     
    US GAAP Effective Tax Rate

     

    22.6

    %

     

    17.3

    %

     

    25.3

    %

     

    45.8

    %

    Non-GAAP Adjusted Effective Tax Rate

     

    25.4

    %

     

    23.1

    %

     

    24.8

    %

     

    23.3

    %

     
    Notes:
    (1) All amounts are approximate due to rounding.
     
    (2) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors.
     
    (3) For the three and six months ended October 31, 2025 and 2024, respectively, substantially all of the tax impact was from deferred taxes.
     
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1)(2)
    RECONCILIATION OF US GAAP NET INCOME TO NON-GAAP EBITDA AND ADJUSTED EBITDA
    (in USD thousands)
    (unaudited)
     
    Three Months Ended Six Months Ended
    October 31, October 31,

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net Income

    $

    44,891

     

    $

    40,458

     

    $

    56,591

     

    $

    39,022

     

    Interest expense

     

    11,670

     

     

    14,463

     

     

    22,712

     

     

    27,250

     

    Provision for income taxes

     

    13,119

     

     

    8,479

     

     

    19,126

     

     

    32,918

     

    Depreciation and amortization

     

    35,929

     

     

    36,718

     

     

    72,375

     

     

    73,971

     

    Non-GAAP EBITDA

     

    105,609

     

     

    100,118

     

     

    170,804

     

     

    173,161

     

    Restructuring and related charges

     

    6,032

     

     

    3,627

     

     

    9,070

     

     

    7,497

     

    Net foreign exchange transaction (gains) losses

     

    (956

    )

     

    3,328

     

     

    15

     

     

    3,094

     

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

     

    2,309

     

     

    (369

    )

     

    3,425

     

     

    (6,170

    )

    Other expense (income), net

     

    1,963

     

     

    (2,226

    )

     

    2,090

     

     

    (3,008

    )

    Held for Sale or Sold segment Adjusted EBITDA

     

    -

     

     

    1,059

     

     

    -

     

     

    3,578

     

    Legal settlement

     

    108

     

     

    -

     

     

    108

     

     

    -

     

    Non-GAAP Adjusted EBITDA

    $

    115,065

     

    $

    105,537

     

    $

    185,512

     

    $

    178,152

     

    Adjusted EBITDA Margin

     

    27.3

    %

     

    24.9

    %

     

    22.7

    %

     

    21.9

    %

     
    Notes:
    (1) All amounts are approximate due to rounding.
     
    (2) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors.
     
    JOHN WILEY & SONS, INC.

    SUPPLEMENTARY INFORMATION (1) (2) (3)

    SEGMENT RESULTS
    (in USD thousands)
    (unaudited)
     
    % Change
    Three Months Ended October 31, Favorable (Unfavorable)

     

    2025

     

     

    2024

     

    Reported Constant

    Currency
    Research:
    Revenue, net
    Research Publishing

    $

    241,382

     

    $

    222,667

     

    8%

    7%

    Research Solutions

     

    37,132

     

     

    39,218

     

    -5%

    -6%

    Total Revenue, net

    $

    278,514

     

    $

    261,885

     

    6%

    5%

     
    Non-GAAP Adjusted Operating Income

    $

    69,961

     

    $

    59,527

     

    18%

    16%

    Depreciation and amortization

     

    23,319

     

     

    22,522

     

    -4%

    -2%

    Non-GAAP Adjusted EBITDA

    $

    93,280

     

    $

    82,049

     

    14%

    13%

    Adjusted EBITDA margin

     

    33.5

    %

     

    31.3

    %

     
    Learning:
    Revenue, net
    Academic

    $

    87,030

     

    $

    94,788

     

    -8%

    -8%

    Professional

     

    56,207

     

     

    66,726

     

    -16%

    -16%

    Total Revenue, net

    $

    143,237

     

    $

    161,514

     

    -11%

    -11%

     
    Non-GAAP Adjusted Operating Income

    $

    46,755

     

    $

    55,871

     

    -16%

    -16%

    Depreciation and amortization

     

    10,680

     

     

    10,897

     

    2%

    2%

    Non-GAAP Adjusted EBITDA

    $

    57,435

     

    $

    66,768

     

    -14%

    -14%

    Adjusted EBITDA margin

     

    40.1

    %

     

    41.3

    %

     
    Held for Sale or Sold:
    Total Revenue, net

    $

    -

     

    $

    3,196

     

    # #
     
    Non-GAAP Adjusted Operating Loss

    $

    -

     

    $

    (1,059

    )

    # #
    Depreciation and amortization

     

    -

     

     

    -

     

    # #
    Non-GAAP Adjusted EBITDA

    $

    -

     

    $

    (1,059

    )

    # #
    Adjusted EBITDA margin

     

    0.0

    %

     

    -33.1

    %

     
    Corporate Expenses:
    Non-GAAP Adjusted Corporate Expenses

    $

    (37,580

    )

    $

    (46,579

    )

    19%

    20%

    Depreciation and amortization

     

    1,930

     

     

    3,299

     

    41%

    42%

    Non-GAAP Adjusted EBITDA

    $

    (35,650

    )

    $

    (43,280

    )

    18%

    18%

     
    Consolidated Results:
    Revenue, net

    $

    421,751

     

    $

    426,595

     

    -1%

    -2%

    Less: Held for Sale or Sold Segment

     

    -

     

     

    (3,196

    )

    # #
    Adjusted Revenue, net

    $

    421,751

     

    $

    423,399

     

    0%

    -1%

     
    Operating Income

    $

    72,996

     

    $

    64,133

     

    14%

    13%

    Adjustments:
    Restructuring charges

     

    6,032

     

     

    3,627

     

    -66%

    -66%

    Held for Sale or Sold Segment Adjusted Operating Loss

     

    -

     

     

    1,059

     

    # #
    Legal settlement

     

    108

     

     

    -

     

    # #
    Non-GAAP Adjusted Operating Income

    $

    79,136

     

    $

    68,819

     

    15%

    14%

    Adjusted Operating Income margin

     

    18.8

    %

     

    16.3

    %

    Depreciation and amortization

     

    35,929

     

     

    36,718

     

    2%

    3%

    Less: Held for Sale or Sold Segment depreciation and amortization

     

    -

     

     

    -

     

    # #
    Non-GAAP Adjusted EBITDA

    $

    115,065

     

    $

    105,537

     

    9%

    8%

    Adjusted EBITDA margin

     

    27.3

    %

     

    24.9

    %

     
    Notes:
    (1) The supplementary information included in this press release for the three and six months ended October 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
     
    (2) All amounts are approximate due to rounding.
     
    (3) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors.
     
    # Variance greater than 100%
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1) (2) (3)
    SEGMENT RESULTS
    (in USD thousands)
    (unaudited)
    % Change
    Six Months Ended October 31, Favorable (Unfavorable)

     

    2025

     

     

    2024

     

    Reported Constant

    Currency
    Research:
    Revenue, net
    Research Publishing

    $

    473,209

     

    $

    453,618

     

    4%

    3%

    Research Solutions

     

    86,997

     

     

    73,576

     

    18%

    17%

    Total Revenue, net

    $

    560,206

     

    $

    527,194

     

    6%

    5%

     
    Non-GAAP Adjusted Operating Income

    $

    126,209

     

    $

    114,743

     

    10%

    10%

    Depreciation and amortization

     

    46,704

     

     

    45,081

     

    -4%

    -2%

    Non-GAAP Adjusted EBITDA

    $

    172,913

     

    $

    159,824

     

    8%

    8%

    Adjusted EBITDA margin

     

    30.9

    %

     

    30.3

    %

     
    Learning:
    Revenue, net
    Academic

    $

    142,502

     

    $

    154,752

     

    -8%

    -8%

    Professional

     

    115,843

     

     

    131,076

     

    -12%

    -12%

    Total Revenue, net

    $

    258,345

     

    $

    285,828

     

    -10%

    -10%

     
    Non-GAAP Adjusted Operating Income

    $

    68,410

     

    $

    78,371

     

    -13%

    -13%

    Depreciation and amortization

     

    20,524

     

     

    22,191

     

    8%

    8%

    Non-GAAP Adjusted EBITDA

    $

    88,934

     

    $

    100,562

     

    -12%

    -12%

    Adjusted EBITDA margin

     

    34.4

    %

     

    35.2

    %

     
    Held for Sale or Sold:
    Total Revenue, net

    $

    -

     

    $

    17,382

     

    # #
     
    Non-GAAP Adjusted Operating Loss

    $

    -

     

    $

    (3,578

    )

    # #
    Depreciation and amortization

     

    -

     

     

    -

     

    # #
    Non-GAAP Adjusted EBITDA

    $

    -

     

    $

    (3,578

    )

    # #
    Adjusted EBITDA margin

     

    0.0

    %

     

    -20.6

    %

     
    Corporate Expenses:
    Non-GAAP Adjusted Corporate Expenses

    $

    (81,482

    )

    $

    (88,933

    )

    8%

    9%

    Depreciation and amortization

     

    5,147

     

     

    6,699

     

    23%

    23%

    Non-GAAP Adjusted EBITDA

    $

    (76,335

    )

    $

    (82,234

    )

    7%

    8%

     
    Consolidated Results:
    Revenue, net

    $

    818,551

     

    $

    830,404

     

    -1%

    -2%

    Less: Held for Sale or Sold Segment

     

    -

     

     

    (17,382

    )

    # #
    Adjusted Revenue, net

    $

    818,551

     

    $

    813,022

     

    1%

    0%

     
    Operating Income

    $

    103,959

     

    $

    93,106

     

    12%

    12%

    Adjustments:
    Restructuring charges

     

    9,070

     

    #

     

    7,497

     

    -21%

    -21%

    Held for Sale or Sold Segment Adjusted Operating Loss

     

    -

     

     

    3,578

     

    # #
    Legal settlement

     

    108

     

     

    -

     

    # #
    Non-GAAP Adjusted Operating Income

    $

    113,137

     

    $

    104,181

     

    9%

    9%

    Adjusted Operating Income margin

     

    13.8

    %

     

    12.8

    %

    Depreciation and amortization

     

    72,375

     

     

    73,971

     

    2%

    3%

    Less: Held for Sale or Sold depreciation and amortization

     

    -

     

     

    -

     

    # #
    Non-GAAP Adjusted EBITDA

    $

    185,512

     

    $

    178,152

     

    4%

    4%

    Adjusted EBITDA margin

     

    22.7

    %

     

    21.9

    %

     
    # Variance greater than 100%
     
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1) (2)
    CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
    (in USD thousands)
    (unaudited)
     
    October 31, April 30,

    2025

    2025

    Assets:
    Current assets
    Cash and cash equivalents

    $

    67,404

    $

    85,882

    Accounts receivable, net

     

    209,679

     

    228,410

    Inventories, net

     

    21,387

     

    22,875

    Prepaid expenses and other current assets

     

    82,753

     

    102,717

    Total current assets

     

    381,223

     

    439,884

     
    Technology, property and equipment, net

     

    146,796

     

    162,125

    Intangible assets, net

     

    581,998

     

    595,044

    Goodwill

     

    1,116,174

     

    1,121,505

    Operating lease right-of-use assets

     

    62,152

     

    66,128

    Other non-current assets

     

    178,396

     

    306,780

    Total assets

    $

    2,466,739

    $

    2,691,466

     
    Liabilities and shareholders' equity:
    Current liabilities
    Accounts payable

    $

    47,654

    $

    60,948

    Accrued royalties

     

    126,130

     

    109,765

    Short-term portion of long-term debt

     

    10,000

     

    10,000

    Contract liabilities

     

    218,787

     

    462,693

    Accrued employment costs

     

    52,796

     

    93,117

    Short-term portion of operating lease liabilities

     

    16,636

     

    18,282

    Other accrued liabilities

     

    68,348

     

    66,051

    Total current liabilities

     

    540,351

     

    820,856

    Long-term debt

     

    861,713

     

    789,435

    Accrued pension liability

     

    72,053

     

    71,899

    Deferred income tax liabilities

     

    102,986

     

    105,145

    Operating lease liabilities

     

    76,278

     

    81,482

    Other long-term liabilities

     

    73,169

     

    70,443

    Total liabilities

     

    1,726,550

     

    1,939,260

    Shareholders' equity

     

    740,189

     

    752,206

    Total liabilities and shareholders' equity

    $

    2,466,739

    $

    2,691,466

     
    Notes:
    (1) The supplementary information included in this press release for October 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
    (2) All amounts are approximate due to rounding.
     
    JOHN WILEY & SONS, INC.
    SUPPLEMENTARY INFORMATION (1) (2)
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (in USD thousands)
    (unaudited)
     
    Six Months Ended
    October 31,

     

    2025

     

     

    2024

     

    Operating activities:
    Net income

    $

    56,591

     

    $

    39,022

     

    Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

     

    3,425

     

     

    (6,170

    )

    Amortization of intangible assets

     

    26,458

     

     

    25,871

     

    Amortization of product development assets

     

    7,663

     

     

    8,622

     

    Depreciation and amortization of technology, property, and equipment

     

    38,254

     

     

    39,478

     

    Other noncash charges

     

    40,325

     

     

    45,638

     

    Net change in operating assets and liabilities

     

    (249,221

    )

     

    (246,453

    )

    Net cash used in operating activities

     

    (76,505

    )

     

    (93,992

    )

     
    Investing activities:
    Additions to technology, property, and equipment

     

    (25,125

    )

     

    (29,030

    )

    Product development spending

     

    (6,296

    )

     

    (7,127

    )

    Businesses acquired in purchase transactions, net of cash acquired

     

    -

     

     

    (915

    )

    Net cash proceeds (transferred) related to the sale of businesses and assets

     

    114,132

     

     

    (8,117

    )

    Acquisitions of publication rights and other

     

    (10,273

    )

     

    700

     

    Net cash provided by (used in) investing activities

     

    72,438

     

     

    (44,489

    )

     
    Financing activities:
    Net debt borrowings

     

    75,501

     

     

    184,066

     

    Cash dividends

     

    (37,772

    )

     

    (38,264

    )

    Purchases of treasury shares

     

    (35,085

    )

     

    (25,421

    )

    Other

     

    (15,617

    )

     

    (7,298

    )

    Net cash (used in) provided by financing activities

     

    (12,973

    )

     

    113,083

     

     
    Effects of exchange rate changes on cash, cash equivalents and restricted cash

     

    (1,438

    )

     

    1,441

     

     
    Change in cash, cash equivalents and restricted cash for period

     

    (18,478

    )

     

    (23,957

    )

     
    Cash, cash equivalents and restricted cash - beginning

     

    85,932

     

     

    99,543

     

    Cash, cash equivalents and restricted cash - ending

    $

    67,454

     

    $

    75,586

     

     
    CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (3)
     
    Six Months Ended
    October 31,

     

    2025

     

     

    2024

     

    Net cash used in operating activities

    $

    (76,505

    )

    $

    (93,992

    )

    Less: Additions to technology, property, and equipment

     

    (25,125

    )

     

    (29,030

    )

    Less: Product development spending

     

    (6,296

    )

     

    (7,127

    )

    Free cash flow less product development spending

    $

    (107,926

    )

    $

    (130,149

    )

     
    Notes:
    (1) The supplementary information included in this press release for the six months ended October 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
     
    (2) All amounts are approximate due to rounding.
     
    (3) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors.

    JOHN WILEY & SONS, INC.

    EXPLANATION OF USAGE OF NON-GAAP PERFORMANCE MEASURES

    In this earnings release and supplemental information, management may present the following non-GAAP performance measures:

    • Adjusted Earnings Per Share (Adjusted EPS);
    • Free Cash Flow less Product Development Spending;
    • Adjusted Revenue;
    • Adjusted Operating Income and margin;
    • Adjusted Income Before Taxes;
    • Adjusted Income Tax Provision;
    • Adjusted Effective Tax Rate;
    • EBITDA, Adjusted EBITDA and margin; and
    • Results on a constant currency basis.

    Management uses these non-GAAP performance measures as supplemental indicators of our operating performance and financial position as well as for internal reporting and forecasting purposes, when publicly providing our outlook, to evaluate our performance and calculate incentive compensation.

    We present these non-GAAP performance measures in addition to US GAAP financial results because we believe that these non-GAAP performance measures provide useful information to certain investors and financial analysts for operational trends and comparisons over time. The use of these non-GAAP performance measures may also provide a consistent basis to evaluate operating profitability and performance trends by excluding items that we do not consider to be controllable activities for this purpose.

    The performance metric used by our chief operating decision maker to evaluate performance of our reportable segments is Adjusted Operating Income. We present both Adjusted Operating Income and Adjusted EBITDA for each of our reportable segments as we believe Adjusted EBITDA provides additional useful information to certain investors and financial analysts for operational trends and comparisons over time. It removes the impact of depreciation and amortization expense, as well as presents a consistent basis to evaluate operating profitability and compare our financial performance to that of our peer companies and competitors.

    For example:

    • Adjusted EPS, Adjusted Revenue, Adjusted Operating Income and margin, Adjusted Income Before Taxes, Adjusted Income Tax Provision, Adjusted Effective Tax Rate, EBITDA, and Adjusted EBITDA and margin provide a more comparable basis to analyze operating results and earnings and are measures commonly used by shareholders to measure our performance.
    • Free Cash Flow less Product Development Spending helps assess our ability, over the long term, to create value for our shareholders as it represents cash available to repay debt, pay common stock dividends, and fund share repurchases and acquisitions.
    • Results on a constant currency basis remove distortion from the effects of foreign currency movements to provide better comparability of our business trends from period to period. We measure our performance excluding the impact of foreign currency (or at constant currency), which means that we apply the same foreign currency exchange rates for the current and equivalent prior period.

    In addition, we have historically provided these or similar non-GAAP performance measures and understand that some investors and financial analysts find this information helpful in analyzing our operating margins and net income, and in comparing our financial performance to that of our peer companies and competitors. Based on interactions with investors, we also believe that our non-GAAP performance measures are regarded as useful to our investors as supplemental to our US GAAP financial results, and that there is no confusion regarding the adjustments or our operating performance to our investors due to the comprehensive nature of our disclosures.

    We have not provided our 2026 outlook for the most directly comparable US GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, gains and losses on foreign currency, and other gains and losses. These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with US GAAP.

    Non-GAAP performance measures do not have standardized meanings prescribed by US GAAP and therefore may not be comparable to the calculation of similar measures used by other companies and should not be viewed as alternatives to measures of financial results under US GAAP. The adjusted metrics have limitations as analytical tools, and should not be considered in isolation from, or as a substitute for, US GAAP information. It does not purport to represent any similarly titled US GAAP information and is not an indicator of our performance under US GAAP. Non-GAAP financial metrics that we present may not be comparable with similarly titled measures used by others. Investors are cautioned against placing undue reliance on these non-GAAP measures.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251204769114/en/

    Brian Campbell

    Investor Relations

    [email protected]

    201.748.6874

    Get the next $WLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WLY
    $WLYB

    CompanyDatePrice TargetRatingAnalyst
    John Wiley & Sons Inc.
    $WLY
    9/8/2022Market Perform → Market Outperform
    CJS Securities
    John Wiley & Sons Inc.
    $WLY
    8/29/2022Market Outperform → Market Perform
    CJS Securities
    More analyst ratings

    $WLY
    $WLYB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

    Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32

    12/10/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl

    11/26/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kissner Matthew S bought $502,028 worth of Class A Common (16,550 units at $30.33), increasing direct ownership by 181% to 25,705 units (SEC Form 4)

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/19/23 6:04:59 PM ET
    $WLY
    Books
    Consumer Discretionary

    Dobson David C bought $152,357 worth of Class A Common (5,081 units at $29.99), increasing direct ownership by 64% to 13,033 units (SEC Form 4) (Amendment)

    4/A - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/19/23 2:50:35 PM ET
    $WLY
    Books
    Consumer Discretionary

    Dobson David C bought $152,357 worth of Class A Common (5,081 units at $29.99), increasing direct ownership by 64% to 13,033 units (SEC Form 4)

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/18/23 4:30:50 PM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    SEC Filings

    View All

    John Wiley & Sons Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/10/25 11:21:47 AM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 10-Q filed by John Wiley & Sons Inc.

    10-Q - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/5/25 9:40:56 AM ET
    $WLY
    Books
    Consumer Discretionary

    John Wiley & Sons Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/4/25 11:00:14 AM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Singh Inder M

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:48:29 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Mcdaniel Raymond W

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:47:08 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Madden Karen N

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:45:44 PM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wiley upgraded by CJS Securities

    CJS Securities upgraded Wiley from Market Perform to Market Outperform

    9/8/22 9:07:27 AM ET
    $WLY
    Books
    Consumer Discretionary

    Wiley downgraded by CJS Securities

    CJS Securities downgraded Wiley from Market Outperform to Market Perform

    8/29/22 10:00:26 AM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Leadership Updates

    Live Leadership Updates

    View All

    Wiley Appoints Katya Andresen to Board of Directors

    Chief Digital & Analytics Officer for The Cigna Group has strong background in technology and AI innovation Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Katya Andresen, chief digital & analytics officer for The Cigna Group, to its Board of Directors. Andresen's background spans technology, data, analytics, and AI innovation across Fortune 500 companies and emerging enterprises. She has led significant initiatives at The Cigna Group and Capital One and successfully transformed Cricket Media by launching a profitable data and digital licensing business. "As we continue to advance our priorities

    6/30/25 8:00:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Appoints Craig Albright as Executive Vice President and Chief Financial Officer

    Seasoned finance executive brings a proven track record in driving profitable growth, improving operational efficiency, and optimizing cash flow Wiley (NYSE:WLY), one of the world's largest publishers and a global leader in research and education, today announced the appointment of Craig Albright as executive vice president and chief financial officer, effective June 26, 2025. Chris Caridi, who has led Wiley's finance organization as interim chief financial officer, will continue with the role of senior vice president, chief accounting officer and finance transformation leader. Albright joins Wiley with over 30 years of global leadership expertise in finance, strategy, and consulting ro

    6/23/25 8:00:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors

    MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is Senior Vice President and Chief Technology Officer at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. At MilliporeSigma, Madden shapes the Technology Roadmap and long-term R&D strategy, systematically exploring emerging opportunities that lead to breakthrough innovations. She leads the Life Science Innovation Board, ensuring a balance o

    3/5/25 8:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Financials

    Live finance-specific insights

    View All

    Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

    Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32

    12/10/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl

    11/26/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    $WLYB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    11/8/24 3:02:29 PM ET
    $WLY
    Books
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    10/23/24 5:04:46 PM ET
    $WLY
    Books
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    10/18/24 8:42:58 AM ET
    $WLY
    Books
    Consumer Discretionary